{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:27:35Z","timestamp":1789586855599,"version":"build-2803163510"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"DST","award":["EMR\/2016\/005878"],"award-info":[{"award-number":["EMR\/2016\/005878"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s11064-019-02805-5","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T18:04:30Z","timestamp":1555697070000},"page":"1517-1532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Possible Molecular Mediators Involved and Mechanistic Insight into Fibromyalgia and Associated Co-morbidities"],"prefix":"10.1007","volume":"44","author":[{"given":"Lovedeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anudeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4180-5812","authenticated-orcid":false,"given":"Manpreet S.","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-7074","authenticated-orcid":false,"given":"Rajbir","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"key":"2805_CR1","first-page":"90","volume":"19","author":"MB Yunus","year":"1992","unstructured":"Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC (1992) Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 19:90\u201394","journal-title":"J Rheumatol"},{"key":"2805_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00002060-199212000-00006","volume":"71","author":"GW Waylonis","year":"1992","unstructured":"Waylonis GW, Heck W (1992) Fibromyalgia syndrome. New associations. Am J Phys Med Rehabil 71:343\u2013348","journal-title":"Am J Phys Med Rehabil"},{"key":"2805_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/0163-8343(93)90020-O","volume":"15","author":"KH Kaplan","year":"1993","unstructured":"Kaplan KH, Goldenberg DL, Galvin-Nadeau M (1993) The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry 15:284\u2013289","journal-title":"Gen Hosp Psychiatry"},{"key":"2805_CR4","first-page":"74","volume":"105","author":"M Rizzi","year":"2017","unstructured":"Rizzi M, Radovanovic D, Santus P, Airoldi A, Frassanito F, Vanni S, Cristiano A, Masala IF, Sarzi-Puttini P (2017) Influence of autonomic nervous system dysfunction in the genesis of sleep disorders in fibromyalgia patients. Clin Exp Rheumatol 105:74\u201380","journal-title":"Clin Exp Rheumatol"},{"key":"2805_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0304-3959(88)90176-5","volume":"34","author":"E Tunks","year":"1988","unstructured":"Tunks E, Crook J, Norman G, Kalaher S (1988) Tender points in fibromyalgia. Pain 34:11\u201319","journal-title":"Pain"},{"key":"2805_CR6","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1002\/art.24849","volume":"60","author":"RE Harris","year":"2009","unstructured":"Harris RE, Sundgren PC, Craig AD, Kirshenbaum E, Sen A, Napadow V, Clauw DJ (2009) Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 60:3146\u20133152","journal-title":"Arthritis Rheum"},{"key":"2805_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/art.1780350509","volume":"35","author":"IJ Russell","year":"1992","unstructured":"Russell IJ, Vaeroy H, Javors M, Nyberg F (1992) Cerebrospinal fluid biogenic amine metabolites in fibromyalgia\/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35:550\u2013556","journal-title":"Arthritis Rheum"},{"key":"2805_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yhbeh.2017.10.011","volume":"97","author":"A Hernandez-Leon","year":"2018","unstructured":"Hernandez-Leon A, De la Luz-Cuellar YE, Granados-Soto V, Gonz\u00e1lez-Trujano ME, Fern\u00e1ndez-Guasti A (2018) Sex differences and estradiol involvement in hyperalgesia and allodynia in an experimental model of fibromyalgia. Horm Behav 97:39\u201346","journal-title":"Horm Behav"},{"key":"2805_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.clineuro.2012.08.028","volume":"115","author":"M Neyal","year":"2013","unstructured":"Neyal M, Yimenicioglu F, Aydeniz A, Taskin A, Saglam S, Cekmen M, Neyal A, Gursoy S, Erel O, Balat A (2013) Plasma nitrite levels, total antioxidant status, total oxidant status, and oxidative stress index in patients with tension-type headache and fibromyalgia. Clin Neurol Neurosurg 115:736\u2013740","journal-title":"Clin Neurol Neurosurg"},{"key":"2805_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00002508-200207000-00008","volume":"18","author":"AE Panerai","year":"2002","unstructured":"Panerai AE, Vecchiet J, Panzeri P, Meroni P, Scarone S, Pizzigallo E, Giamberardino MA, Sacerdote P (2002) Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report. Clin J Pain 18:270\u2013273","journal-title":"Clin J Pain"},{"key":"2805_CR11","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jpsychires.2006.02.007","volume":"41","author":"C Laske","year":"2007","unstructured":"Laske C, Stransky E, Eschweiler GW, Klein R, Wittorf A, Leyhe T, Richartz E, K\u00f6hler N, Bartels M, Buchkremer G, Schott K (2007) Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatry Res 41:600\u2013605","journal-title":"J Psychiatry Res"},{"key":"2805_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrrheum.2011.98","volume":"7","author":"T Schmidt-Wilcke","year":"2011","unstructured":"Schmidt-Wilcke T, Clauw DJ (2011) Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol 7:518","journal-title":"Nat Rev Rheumatol"},{"key":"2805_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1155\/2008\/959036","volume":"13","author":"JE Sumpton","year":"2008","unstructured":"Sumpton JE, Moulin DE (2008) Fibromyalgia: presentation and management with a focus on pharmacological treatment. Pain Res Manag 13:477\u2013483","journal-title":"Pain Res Manag"},{"key":"2805_CR14","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","volume":"1","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C, Walitt B (2015) Fibromyalgia. Nat Rev Dis Primers 1:15022","journal-title":"Nat Rev Dis Primers"},{"key":"2805_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, Clauw DJ, FitzCharles M, Goldenerberg D, H\u00e4user W, Katz RS, Russell IJ, Mease PJ, Russell A, Walitt B (2016) Revisions to the 2010\/2011 fibromyalgia diagnostic criteria [abstract]. Semin Arthritis Rheum 46:319\u2013329","journal-title":"Semin Arthritis Rheum"},{"key":"2805_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.rbr.2017.05.006","volume":"57","author":"RE Heymann","year":"2017","unstructured":"Heymann RE, Paiva ES, Martinez JE, Helfenstein M Jr, Rezende MC, Provenza JR, Ranzolin A, Assis MR, Feldman DP, Ribeiro LS, Souza EJR (2017) New guidelines for the diagnosis of fibromyalgia. Rev Bras Reumatol Engl Ed 57:467\u2013476","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"2805_CR17","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","volume":"163","author":"MJ Bair","year":"2003","unstructured":"Bair MJ, Robinson RL, Katon W, Kroenke K (2003) Depression and pain comorbidity: a literature review. Arch Intern Med 163:2433\u20132445","journal-title":"Arch Intern Med"},{"key":"2805_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/biomedicines5020020","volume":"5","author":"S Kia","year":"2017","unstructured":"Kia S, Choy E (2017) Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomedicines 5:20","journal-title":"Biomedicines"},{"key":"2805_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","volume":"145","author":"W H\u00e4user","year":"2009","unstructured":"H\u00e4user W, Bernardy K, U\u00e7eyler N, Sommer C (2009) Treatment of fibromyalgia syndrome with gabapentin and pregabalin: a meta-analysis of randomized controlled trials. Pain 145:69\u201381","journal-title":"Pain"},{"key":"2805_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1037\/pha0000194","volume":"26","author":"J Rheker","year":"2018","unstructured":"Rheker J, Rief W, Doering BK, Winkler A (2018) Assessment of adverse events in clinical drug trials: identifying amitriptyline\u2019s placebo- and baseline-controlled side effects. Exp Clin Psychopharmacol 26:320\u2013326","journal-title":"Exp Clin Psychopharmacol"},{"key":"2805_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1526-4637.2011.01286.x","volume":"13","author":"P Kulshreshtha","year":"2012","unstructured":"Kulshreshtha P, Gupta R, Yadav RK, Bijlani RL, Deepak KK (2012) Effect of low-dose amitriptyline on autonomic functions and peripheral blood flow in fibromyalgia: a pilot study. Pain Med 13:131\u2013136","journal-title":"Pain Med"},{"key":"2805_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1476-5381.1991.tb12502.x","volume":"104","author":"FQ Cunha","year":"1991","unstructured":"Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH (1991) Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 104:765\u2013767","journal-title":"Br J Pharmacol"},{"key":"2805_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jpain.2007.05.002","volume":"8","author":"P Sarchielli","year":"2007","unstructured":"Sarchielli P, Mancini ML, Floridi A, Coppola F, Rossi C, Nardi K, Acciarresi M, Pini LA, Calabresi P (2007) Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain 8:737\u2013745","journal-title":"J Pain"},{"key":"2805_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/rheumatology\/40.7.743","volume":"40","author":"DJ Wallace","year":"2001","unstructured":"Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH (2001) Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 40:743\u2013749","journal-title":"Rheumatology"},{"key":"2805_CR25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/1529-0131(200004)43:4<872::AID-ANR19>3.0.CO;2-T","volume":"43","author":"DJ Torpy","year":"2000","unstructured":"Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR (2000) Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 43:872\u2013880","journal-title":"Arthritis Rheum"},{"key":"2805_CR26","first-page":"158","volume":"19","author":"IJ Russell","year":"1989","unstructured":"Russell IJ, Michalek JE, Vipraio GA, Fletcher EM, Wall K (1989) Serum amino acids in fibrositis\/fibromyalgia syndrome. J Rheumatol Suppl 19:158\u2013163","journal-title":"J Rheumatol Suppl"},{"key":"2805_CR27","first-page":"458","volume":"88","author":"T Stratz","year":"1993","unstructured":"Stratz T, Samborski W, Hrycaj P, Pap T, Mackiewicz S, Mennet P, M\u00fcller W (1993) Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis. Med Klin 88:458\u2013462","journal-title":"Med Klin"},{"key":"2805_CR28","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1002\/art.20485","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50:2974\u20132984","journal-title":"Arthritis Rheum"},{"key":"2805_CR29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3899\/jrheum.080734","volume":"36","author":"PJ Mease","year":"2009","unstructured":"Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH (2009) The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial. J Rheumatol 36:398\u2013409","journal-title":"J Rheumatol"},{"key":"2805_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00296-007-0454-y","volume":"28","author":"S G\u00fcrsoy","year":"2008","unstructured":"G\u00fcrsoy S, Erdal E, Sezgin M, Barlas IO, Aydeniz A, Ala\u015fehirli B, Sahin G (2008) Which genotype of the MAO gene that the patients have are likely to be most susceptible to the symptoms of fibromyalgia? Rheumatol Int 28:307\u2013311","journal-title":"Rheumatol Int"},{"key":"2805_CR31","doi-asserted-by":"crossref","unstructured":"Tort S, Urr\u00fatia G, Nishishinya MB, Walitt B (2012) Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome. Cochrane Database Syst Rev CD009807","DOI":"10.1002\/14651858.CD009807"},{"key":"2805_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0304-3959(97)03334-4","volume":"71","author":"R Kolhekar","year":"1997","unstructured":"Kolhekar R, Murphy S, Gebhart GF (1997) Thalamic NMDA receptors modulate inflammation-produced hyperalgesia in the rat. Pain 71:31\u201340","journal-title":"Pain"},{"key":"2805_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3959(02)00140-9","volume":"98","author":"V Neugebauer","year":"2002","unstructured":"Neugebauer V (2002) Metabotropic glutamate receptors\u2013important modulators of nociception and pain behavior. Pain 98:1\u20138","journal-title":"Pain"},{"key":"2805_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pbb.2013.04.007","volume":"108","author":"S Ogino","year":"2013","unstructured":"Ogino S, Nagakura Y, Tsukamoto M, Watabiki T, Ozawa T, Oe T, Shimizu Y, Ito H (2013) Systemic administration of 5-HT(2C) receptor agonists attenuates muscular hyperalgesia in reserpine-induced myalgia model. Pharmacol Biochem Behav 108:8\u201315","journal-title":"Pharmacol Biochem Behav"},{"key":"2805_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/00006842-197507000-00008","volume":"37","author":"H Moldofsky","year":"1975","unstructured":"Moldofsky H, Scarisbrick P, England R, Smythe H (1975) Musculosketal symptoms and non-REM sleep disturbance in patients with \u201cfibrositis syndrome\u201d and healthy subjects. Psychosom Med 37:341\u2013351","journal-title":"Psychosom Med"},{"key":"2805_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0306-4530(92)90017-2","volume":"17","author":"R Klein","year":"1992","unstructured":"Klein R, B\u00e4nsch M, Berg PA (1992) Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome. Psychoneuroendocrinology 17:593\u2013598","journal-title":"Psychoneuroendocrinology"},{"key":"2805_CR37","first-page":"21","volume":"1","author":"R Klein","year":"1995","unstructured":"Klein R, Berg PA (1995) High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders. Eur J Med Res 1:21\u201326","journal-title":"Eur J Med Res"},{"key":"2805_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/(SICI)1099-1077(199803)13:2<137::AID-HUP950>3.0.CO;2-X","volume":"13","author":"W Samborski","year":"1998","unstructured":"Samborski W, Sluzewska A, Lacki JK, Sobieska M, Klein R, Mackiewicz S (1998) Antibodies against serotonin and gangliosides in patients with fibromyalgia and major depression. Hum Psychopharmacol 13:137\u2013138","journal-title":"Hum Psychopharmacol"},{"key":"2805_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/BF01452251","volume":"17","author":"R Olin","year":"1998","unstructured":"Olin R, Klein R, Berg PA (1998) A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of auto-antibodies to serotonin, gangliosides and phospholipids. Clin Rheumatol 17:89\u201394","journal-title":"Clin Rheumatol"},{"key":"2805_CR40","first-page":"54","volume":"35","author":"DJ Park","year":"2017","unstructured":"Park DJ, Takahashi Y, Kang JH, Yim YR, Kim JE, Lee JW, Lee KE, Lee JK, Lee SS (2017) Anti-N-methyl-D-aspartate receptor antibodies are associated with fibromyalgia in patients with systemic lupus erythematosus: a case\u2013control study. Clin Exp Rheumatol 35:54\u201360","journal-title":"Clin Exp Rheumatol"},{"key":"2805_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/rheumatology\/40.3.290","volume":"40","author":"E Legangneux","year":"2001","unstructured":"Legangneux E, Mora JJ, Spreux-Varoquaux O, Thorin I, Herrou M, Alvado G, Gomeni C (2001) Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H] imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology 40:290\u2013296","journal-title":"Rheumatology"},{"key":"2805_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jpsychores.2011.09.010","volume":"72","author":"R Riva","year":"2012","unstructured":"Riva R, Mork PJ, Westgaard RH, Okkenhaug Johansen T, Lundberg U (2012) Catecholamines and heart rate in female fibromyalgia patients. J Psychosom Res 72:51\u201357","journal-title":"J Psychosom Res"},{"key":"2805_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.euroneuro.2015.12.007","volume":"26","author":"K Ledermann","year":"2016","unstructured":"Ledermann K, Jenewein J, Sprott H, Hasler G, Schnyder U, Warnock G, Johayem A, Kollias S, Buck A, Martin-Soelch C (2016) Relation of dopamine receptor 2 binding to pain perception in female fibromyalgia patients with and without depression: A [11C] raclopride PET-study. Eur Neuropsychopharmacol 26:320\u2013330","journal-title":"Eur Neuropsychopharmacol"},{"key":"2805_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0165-0327(02)00025-3","volume":"75","author":"EA Malt","year":"2003","unstructured":"Malt EA, Olafsson S, Aakvaag A, Lund A, Ursin H (2003) Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. J Affect Disord 75:77\u201382","journal-title":"J Affect Disord"},{"key":"2805_CR45","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jpain.2008.12.008","volume":"10","author":"PB Wood","year":"2009","unstructured":"Wood PB, Glabus MF, Simpson R, Patterson JC (2009) Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism. J Pain 10:609\u2013618","journal-title":"J Pain"},{"key":"2805_CR46","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/01.rhu.0000081264.26484.e5","volume":"9","author":"AJ Holman","year":"2003","unstructured":"Holman AJ (2003) Ropinirole, open preliminary observations of a dopamine agonist for refractory fibromyalgia. J Clin Rheumatol 9:277\u2013279","journal-title":"J Clin Rheumatol"},{"key":"2805_CR47","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/art.21191","volume":"52","author":"AJ Holman","year":"2005","unstructured":"Holman AJ, Myers RR (2005) A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum 52:2495\u20132505","journal-title":"Arthritis Rheum"},{"key":"2805_CR48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.tins.2004.08.001","volume":"27","author":"MP Mattson","year":"2004","unstructured":"Mattson MP, Maudsley S, Martin B (2004) BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 27:589\u2013594","journal-title":"Trends Neurosci"},{"key":"2805_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1517\/14728222.2014.994506","volume":"19","author":"J Nijs","year":"2015","unstructured":"Nijs J, Meeus M, Versijpt J, Moens M, Bos I, Knaepen K, Meeusen R (2015) Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target? Expert Opin Ther Targets 19:565\u2013576","journal-title":"Expert Opin Ther Targets"},{"key":"2805_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.neuint.2013.01.001","volume":"62","author":"B Nugraha","year":"2013","unstructured":"Nugraha B, Korallus C, Gutenbrunner C (2013) Serum level of brain-derived neurotrophic factor in fibromyalgia syndrome correlates with depression but not anxiety. Neurochem Int 62:281\u2013286","journal-title":"Neurochem Int"},{"key":"2805_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cyto.2016.05.011","volume":"84","author":"A Ranzolin","year":"2016","unstructured":"Ranzolin A, Duarte AL, Bredemeier M, da Costa Neto CA, Ascoli BM, Wollenhaupt-Aguiar B, Kapczinski F, Xavier RM (2016) Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia: a controlled cross-sectional study. Cytokine 84:25\u201328","journal-title":"Cytokine"},{"key":"2805_CR52","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S0006-3223(00)00935-5","volume":"48","author":"RS Duman","year":"2000","unstructured":"Duman RS, Malberg J, Nakagawa S, D\u2019Sa C (2000) Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48:732\u2013739","journal-title":"Biol Psychiatry"},{"key":"2805_CR53","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","volume":"109","author":"F Karege","year":"2002","unstructured":"Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM (2002) Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109:143\u2013148","journal-title":"Psychiatry Res"},{"key":"2805_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2007.06.054","volume":"1169","author":"U Hoheisel","year":"2007","unstructured":"Hoheisel U, Unger T, Mense S (2007) Sensitization of rat dorsal horn neurons by NGF-induced sub threshold potentials and low-frequency activation. A study employing intracellular recordings in vivo. Brain Res 1169:34\u201343","journal-title":"Brain Res"},{"key":"2805_CR55","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pneurobio.2008.04.004","volume":"85","author":"A Merighi","year":"2008","unstructured":"Merighi A, Salio C, Ghirri A, Lossi L, Ferrini F, Betelli C, Bardoni R (2008) BDNF as a pain modulator. Prog Neurobiol 85:297\u2013317","journal-title":"Prog Neurobiol"},{"key":"2805_CR56","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/ALN.0000000000000017","volume":"119","author":"RE Harris","year":"2013","unstructured":"Harris RE, Napadow V, Huggins JP, Pauer L, Kim J, Hampson J, Sundgren PC, Foerster B, Petrou M, Schmidt-Wilcke T, Clauw DJ (2013) Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology 119:1453\u20131464","journal-title":"Anesthesiology"},{"key":"2805_CR57","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/AJP.0000000000000474","volume":"33","author":"TL Pyke","year":"2017","unstructured":"Pyke TL, Osmotherly PG, Baines S (2017) Measuring glutamate levels in the brains of fibromyalgia patients and a potential role for glutamate in the pathophysiology of fibromyalgia symptoms: a systematic review. Clin J Pain 33:944\u2013954","journal-title":"Clin J Pain"},{"key":"2805_CR58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jpain.2005.12.010","volume":"7","author":"SP Cohen","year":"2006","unstructured":"Cohen SP, Verdolin MH, Chang AS, Kurihara C, Morlando BJ, Mao J (2006) The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain 7:391\u2013398","journal-title":"J Pain"},{"key":"2805_CR59","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3109\/03009749509095181","volume":"24","author":"J S\u00f6rensen","year":"1995","unstructured":"S\u00f6rensen J, Bengtsson A, B\u00e4ckman E, Henriksson KG, Bengtsson M (1995) Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 24:360\u2013365","journal-title":"Scand J Rheumatol"},{"key":"2805_CR60","doi-asserted-by":"publisher","first-page":"25082","DOI":"10.1074\/jbc.M000183200","volume":"275","author":"SL Rogalski","year":"2000","unstructured":"Rogalski SL, Appleyard SM, Pattillo A, Terman GW, Chavkin C (2000) TrkB activation by brain-derived neurotrophic factor inhibits the G protein-gated inward rectifier Kir3 by tyrosine phosphorylation of the channel. J Biol Chem 275:25082\u201325088","journal-title":"J Biol Chem"},{"key":"2805_CR61","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1083\/jcb.200305134","volume":"163","author":"J Du","year":"2003","unstructured":"Du J, Feng L, Zaitsev E, Je HS, Liu XW, Lu B (2003) Regulation of TrkB receptor tyrosine kinase and its internalization by neuronal activity and Ca2+ influx. J Cell Biol 163:385\u2013395","journal-title":"J Cell Biol"},{"key":"2805_CR62","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1523\/JNEUROSCI.3686-05.2006","volume":"26","author":"W Guo","year":"2006","unstructured":"Guo W, Robbins MT, Wei F, Zou S, Dubner R, Ren K (2006) Supraspinal brain-derived neurotrophic factor signaling: a novel mechanism for descending pain facilitation. J Neurosci 26:126\u2013137","journal-title":"J Neurosci"},{"key":"2805_CR63","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neuroscience.2014.03.054","volume":"269","author":"H Wong","year":"2014","unstructured":"Wong H, Kang I, Dong XD, Christidis N, Ernberg M, Svensson P, Cairns BE (2014) NGF-induced mechanical sensitization of the masseter muscle is mediated through peripheral NMDA receptors. Neuroscience 269:232\u2013244","journal-title":"Neuroscience"},{"key":"2805_CR64","first-page":"5936","volume":"272","author":"G Bai","year":"1997","unstructured":"Bai G, Kusiak JW (1997) Nerve growth factor up-regulates the N-methyl-D-aspartate receptor subunit 1 promoter in PC12 cells. J BiolChem 272:5936\u20135942","journal-title":"J BiolChem"},{"key":"2805_CR65","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jpain.2005.01.357","volume":"6","author":"R Staud","year":"2005","unstructured":"Staud R, Vierck CJ, Robinson ME, Price DD (2005) Effects of the N-methyl-D-aspartate receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal control subjects. J Pain 6:323\u2013332","journal-title":"J Pain"},{"key":"2805_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J (2007) Cytokines, inflammation and pain. Int Anesthesiol Clin 45:27\u201337","journal-title":"Int Anesthesiol Clin"},{"key":"2805_CR67","first-page":"1","volume":"521","author":"LR Watkins","year":"2003","unstructured":"Watkins LR, Milligan ED, Maier SF (2003) Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol 521:1\u201321","journal-title":"Adv Exp Med Biol"},{"key":"2805_CR68","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0306-4530(98)00087-0","volume":"24","author":"M Maes","year":"1999","unstructured":"Maes M, Libbrecht I, Van Hunsel F, Lin AH, De Clerck L, Stevens W, Kenis G, de Jongh R, Bosmans E, Neels H (1999) The immune-inflammatory pathophysiology of fibromyalgia: increased serum soluble gp130, the common signal transducer protein of various neurotrophic cytokines. Psychoneuroendocrinology 24:371\u2013383","journal-title":"Psychoneuroendocrinology"},{"key":"2805_CR69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jneuroim.2015.11.011","volume":"290","author":"D Mendieta","year":"2016","unstructured":"Mendieta D, De la Cruz-Aguilera DL, Barrera-Villalpando MI, Becerril-Villanueva E, Arreola R, Hern\u00e1ndez-Ferreira E, P\u00e9rez-Tapia SM, P\u00e9rez-S\u00e1nchez G, Garc\u00e9s-Alvarez ME, Aguirre-Cruz L, Velasco-Vel\u00e1zquez MA, Pav\u00f3n L (2016) IL-8 and IL-6 primarily mediate the inflammatory response in fibromyalgia patients. J Neuroimmunol 290:22\u201325","journal-title":"J Neuroimmunol"},{"key":"2805_CR70","first-page":"146","volume":"30","author":"S Salemi","year":"2003","unstructured":"Salemi S, Rethage J, Wollina U, Michel BA, Gay RE, Gay S, Sprott H (2003) Detection of interleukin 1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha in skin of patients with fibromyalgia. J Rheumatol 30:146\u2013150","journal-title":"J Rheumatol"},{"key":"2805_CR71","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/art.1780340712","volume":"34","author":"N Hader","year":"1991","unstructured":"Hader N, Rimon D, Kinarty A, Lahat N (1991) Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome. Arthritis Rheum 34:866\u2013872","journal-title":"Arthritis Rheum"},{"key":"2805_CR72","first-page":"358","volume":"29","author":"A G\u00fcr","year":"2002","unstructured":"G\u00fcr A, Karako\u00e7 M, Nas K, Remzi Cevik, Denli A, Sara\u00e7 J (2002) Cytokines and depression in cases with fibromyalgia. J Rheumatol 29:358\u2013361","journal-title":"J Rheumatol"},{"key":"2805_CR73","first-page":"225","volume":"25","author":"L Bazzichi","year":"2007","unstructured":"Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F, Ciapparelli A, Dell\u2019Osso L, Bombardieri S (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25:225\u2013230","journal-title":"Clin Exp Rheumatol"},{"key":"2805_CR74","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3181\/0808-RM-254","volume":"234","author":"F Togo","year":"2009","unstructured":"Togo F, Natelson BH, Adler GK, Ottenweller JE, Goldenberg DL, Struzik ZR, Yamamoto Y (2009) Plasma cytokine fluctuations over time in healthy controls and patients with fibromyalgia. Exp Biol Med 234:232\u2013240","journal-title":"Exp Biol Med"},{"key":"2805_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jneuroim.2011.10.013","volume":"242","author":"D Kadetoff","year":"2012","unstructured":"Kadetoff D, Lampa J, Westman M, Andersson M, Kosek E (2012) Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels. J Neuroimmunol 242:33\u201338","journal-title":"J Neuroimmunol"},{"key":"2805_CR76","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1365-2249.2003.02149.x","volume":"132","author":"MRA Kashipaz","year":"2003","unstructured":"Kashipaz MRA, Swinden D, Todd I, Powell RJ (2003) Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol 132:360\u2013365","journal-title":"Clin Exp Immunol"},{"key":"2805_CR77","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.pnpbp.2007.03.004","volume":"31","author":"YK Kim","year":"2007","unstructured":"Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB (2007) Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31:1044\u20131053","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2805_CR78","first-page":"597","volume":"11","author":"P Yang","year":"2015","unstructured":"Yang P, Gao Z, Zhang H, Fang Z, Wu C, Xu H, Huang QJ (2015) Changes in proinflammatory cytokines and white matter in chronically stressed rats. Neuropsychiatr Dis Treat 11:597\u2013607","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2805_CR79","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1097\/00001756-199709080-00007","volume":"8","author":"HC Shin","year":"1997","unstructured":"Shin HC, Oh S, Jung SC, Park J, Won CK (1997) Differential modulation of short and long latency sensory responses in the SI cortex by IL-6. NeuroReport 8:2841\u20132844","journal-title":"NeuroReport"},{"key":"2805_CR80","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0014-2999(97)01196-5","volume":"334","author":"K Yabuuchi","year":"1997","unstructured":"Yabuuchi K, Maruta E, Yamamoto J, Nishiyori A, Takami S, Minami M, Satoh M (1997) Intracerebroventricular injection of isoproterenol produces its analgesic effect through interleukin-1beta production. Eur J Pharmacol 334:133\u2013140","journal-title":"Eur J Pharmacol"},{"key":"2805_CR81","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1165\/ajrcmb.21.3.3549","volume":"21","author":"YA Schwarz","year":"1999","unstructured":"Schwarz YA, Amin RS, Stark JM, Trapnell BC, Wilmott RW (1999) Interleukin-1 receptor antagonist inhibits interleukin-8 expression in A549 respiratory epithelial cells infected in vitro with a replication-deficient recombinant adenovirus vector. Am J Respir Cell Mol Biol 21:388\u2013394","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2805_CR82","first-page":"2273","volume":"24","author":"JB Harley","year":"1998","unstructured":"Harley JB, Gallagher G (1998) Lupus and interleukin 10. J Rheumatol 24:2273\u20132275","journal-title":"J Rheumatol"},{"key":"2805_CR83","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10067-010-1599-8","volume":"30","author":"KI Cho","year":"2011","unstructured":"Cho KI, Lee JH, Kim SM, Lee HG, Kim TI (2011) Assessment of endothelial function in patients with fibromyalgia\u2013cardiac ultrasound study. Clin Rheumatol 30:647\u2013654","journal-title":"Clin Rheumatol"},{"key":"2805_CR84","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.clinbiochem.2011.01.011","volume":"44","author":"G Topal","year":"2011","unstructured":"Topal G, Donmez A, Do\u011fan BS, Kucur M, Cengiz DT, Berkoz FB, Erdogan N (2011) Asymmetric dimethylarginine (ADMA) levels are increased in patients with fibromyalgia: correlation with tumor necrosis factor-\u03b1 (TNF-\u03b1) and 8-iso-prostaglandin F(2\u03b1) (8-iso-PGF(2\u03b1)). Clin Biochem 44:364\u2013367","journal-title":"Clin Biochem"},{"key":"2805_CR85","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/rheumatology\/keg131","volume":"42","author":"M Pache","year":"2003","unstructured":"Pache M, Ochs J, Genth E, Mierau R, Kube T, Flammer J (2003) Increased plasma endothelin-1 levels in fibromyalgia syndrome. Rheumatology 42:493\u2013494","journal-title":"Rheumatology"},{"key":"2805_CR86","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.3892\/mmr.2017.7395","volume":"16","author":"SS Nah","year":"2017","unstructured":"Nah SS, Lee H, Hong Y, Im J, Won H, Chang SH, Kim HK, Kwon JT, Kim HJ (2017) Association between endothelin-1 and fibromyalgia syndrome. Mol Med Rep 16:6234\u20136239","journal-title":"Mol Med Rep"},{"key":"2805_CR87","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/01.CIR.92.3.357","volume":"92","author":"WG Haynes","year":"1995","unstructured":"Haynes WG, Strachan FE, Webb DJ (1995) Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92:357\u2013363","journal-title":"Circulation"},{"key":"2805_CR88","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/07853890500472151","volume":"38","author":"RH Boger","year":"2006","unstructured":"Boger RH (2006) Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 38:126\u2013136","journal-title":"Ann Med"},{"key":"2805_CR89","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/art.22424","volume":"56","author":"A Surdacki","year":"2007","unstructured":"Surdacki A, Martens-Lobenhoffer J, Wloch A, Marewicz E, Rakowski T, WieczorekSurdacka E (2007) Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 56:809\u2013819","journal-title":"Arthritis Rheum"},{"key":"2805_CR90","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1161\/01.CIR.99.24.3092","volume":"99","author":"A Ito","year":"1999","unstructured":"Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP (1999) Novel mechanism for endothelial dysfunction: dysregulation of dimethyl arginine dimethylaminohydrolase. Circulation 99:3092\u20133095","journal-title":"Circulation"},{"key":"2805_CR91","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0002-9343(92)90265-D","volume":"92","author":"JI Hudson","year":"1992","unstructured":"Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L (1992) Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92:363\u2013367","journal-title":"Am J Med"},{"key":"2805_CR92","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/head.12590","volume":"55","author":"B Vij","year":"2015","unstructured":"Vij B, Whipple MO, Tepper SJ, Mohabbat AB, Stillman M, Vincent A (2015) Frequency of migraine headaches in patients with fibromyalgia. Headache 55:860\u2013865","journal-title":"Headache"},{"key":"2805_CR93","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/head.13191","volume":"57","author":"SJ Cho","year":"2017","unstructured":"Cho SJ, Sohn JH, Bae JS, Chu MK (2017) Fibromyalgia among patients with Chronic migraine and chronic tension-type headache: a multicenter prospective cross-sectional study. Headache 57:1583\u20131592","journal-title":"Headache"},{"key":"2805_CR94","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1046\/j.1526-4610.1998.3806465.x","volume":"38","author":"I Munno","year":"1998","unstructured":"Munno I, Centonze V, Marinaro M, Bassi A, Lacedra G, Causarano V, Nardelli P, Cassiano MA, Albano O (1998) Cytokines and migraine: increase of IL-5 and IL-4 plasma levels. Headache 38:465\u2013467","journal-title":"Headache"},{"key":"2805_CR95","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1526-4610.2005.05135.x","volume":"45","author":"F Perini","year":"2005","unstructured":"Perini F, D\u2019Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V (2005) Plasma cytokine levels in migraineurs and controls. Headache 45:926\u2013931","journal-title":"Headache"},{"key":"2805_CR96","first-page":"307","volume":"12","author":"M Ayd\u0131n","year":"2015","unstructured":"Ayd\u0131n M, Feyzi-Demir C, Ar\u0131kano\u011flu A, Bulut S, \u0130lhan N (2015) Plasma cytokine levels in migraineurs during and outside of attacks. Eur J Gen Med 12:307\u2013312","journal-title":"Eur J Gen Med"},{"key":"2805_CR97","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ecl.2013.02.002","volume":"42","author":"JD Veldhuis","year":"2013","unstructured":"Veldhuis JD, Sharma A, Roelfsema F (2013) Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis. Endocrinol Metab Clin N Am 42:201\u2013225","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2805_CR98","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/305325a0","volume":"305","author":"C Rivier","year":"1983","unstructured":"Rivier C, Vale W (1983) Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305:325\u2013327","journal-title":"Nature"},{"key":"2805_CR99","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.1780371105","volume":"37","author":"LJ Crofford","year":"1994","unstructured":"Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, Sternberg EM, Gold PW, Chrousos GP, Wilder RL (1994) Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37:1583\u20131592","journal-title":"Arthritis Rheum"},{"key":"2805_CR100","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0002-9343(99)00074-1","volume":"106","author":"GK Adler","year":"1999","unstructured":"Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL (1999) Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106:534\u2013543","journal-title":"Am J Med"},{"key":"2805_CR101","first-page":"469","volume":"20","author":"EN Griep","year":"1993","unstructured":"Griep EN, Boersma JW, de Kloet ER (1993) Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20:469\u2013474","journal-title":"J Rheumatol"},{"key":"2805_CR102","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1124\/jpet.115.230060","volume":"356","author":"I Tsilioni","year":"2016","unstructured":"Tsilioni I, Russell IJ, Stewart JM, Gleason RM, Theoharides TC (2016) Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells. J Pharmacol Exp Ther 356:664\u2013672","journal-title":"J Pharmacol Exp Ther"},{"key":"2805_CR103","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/sj.npp.1301200","volume":"31","author":"SA McLean","year":"2006","unstructured":"McLean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G, Park KM, Liberzon I, Sen A, Gracely RH, Baraniuk JN, Clauw DJ (2006) Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology 31:2776\u20132782","journal-title":"Neuropsychopharmacology"},{"key":"2805_CR104","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1126\/science.1093065","volume":"303","author":"TD Wager","year":"2004","unstructured":"Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD (2004) Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303:1162\u20131167","journal-title":"Science"},{"key":"2805_CR105","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0006-8993(99)02114-9","volume":"850","author":"S Makino","year":"1999","unstructured":"Makino S, Shibasaki T, Yamauchi N, Nishioka T, Mimoto T, Wakabayashi I, Gold PW, Hashimoto K (1999) Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat. Brain Res 850:136\u2013143","journal-title":"Brain Res"},{"key":"2805_CR106","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2017.10.022","volume":"112","author":"G Fatima","year":"2017","unstructured":"Fatima G, Mahdi F (2017) Deciphering the role of oxidative and antioxidative parameters and toxic metal ion content in women with fibromyalgia syndrome. Free Radic Biol Med 112:23\u201324","journal-title":"Free Radic Biol Med"},{"key":"2805_CR107","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.clinbiochem.2008.12.010","volume":"42","author":"MD Cordero","year":"2009","unstructured":"Cordero MD, Moreno-Fern\u00e1ndez AM, deMiguel M, Bonal P, Campa F, Jim\u00e9nez-Jim\u00e9nez LM, Ruiz-Losada A, S\u00e1nchez-Dom\u00ednguez B, S\u00e1nchez Alc\u00e1zar JA, Salviati L, Navas P (2009) Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia. Clin Biochem 42:732\u2013735","journal-title":"Clin Biochem"},{"key":"2805_CR108","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/147323000203000213","volume":"30","author":"RE Lister","year":"2002","unstructured":"Lister RE (2002) An open, pilot study to evaluate the potential benefits of coenzyme Q10 combined with Ginkgo biloba extract in fibromyalgia syndrome. J Int Med Res 30:195\u2013199","journal-title":"J Int Med Res"},{"key":"2805_CR109","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00296-003-0427-8","volume":"25","author":"S Bagis","year":"2005","unstructured":"Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B, Erdogan C (2005) Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int 25:188\u2013190","journal-title":"Rheumatol Int"},{"key":"2805_CR110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","volume":"111","author":"AC Andreazza","year":"2008","unstructured":"Andreazza AC, Kauer-Sant\u2019anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, Yatham LN (2008) Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 111:135\u2013144","journal-title":"J Affect Disord"},{"key":"2805_CR111","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PSY.0000000000000009","volume":"76","author":"P Palta","year":"2014","unstructured":"Palta P, Samuel LJ, Miller ER 3rd, Szanton SL (2014) Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom Med 76:12\u201319","journal-title":"Psychosom Med"},{"key":"2805_CR112","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1023\/A:1006912010550","volume":"199","author":"C Curti","year":"1999","unstructured":"Curti C, Mingatto FE, Polizello AC, Galastri LO, Uyemura SA, Santos AC (1999) Fluoxetine interacts with the lipid bilayer of the inner membrane in isolated rat brain mitochondria, inhibiting electron transport and F1F0-ATPase activity. Mol Cell Biochem 199:103\u2013109","journal-title":"Mol Cell Biochem"},{"key":"2805_CR113","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.pnpbp.2008.05.024","volume":"32","author":"AJ Schmidt","year":"2008","unstructured":"Schmidt AJ, Heiser P, Hemmeter UM, Krieg JC, Vedder H (2008) Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells. Prog Neuropsychopharmacol Biol Psychiatry 32:1567\u20131573","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2805_CR114","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2377-11-55","volume":"11","author":"J Koroschetz","year":"2011","unstructured":"Koroschetz J, Rehm SE, Gockel U, Brosz M, Freynhagen R, T\u00f6lle TR, Baron R (2011) Fibromyalgia and neuropathic pain\u2013differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurol 11:55","journal-title":"BMC Neurol"},{"key":"2805_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2014.01.014","volume":"68","author":"NN Pathak","year":"2014","unstructured":"Pathak NN, Balaganur V, Lingaraju MC, Kant V, Latief N, More AS, Kumar D, Kumar D, Tandan SK (2014) Atorvastatin attenuates neuropathic pain in rat neuropathy model by down-regulating oxidative damage at peripheral, spinal and supraspinal levels. Neurochem Int 68:1\u20139","journal-title":"Neurochem Int"},{"key":"2805_CR116","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2174\/092986707780059607","volume":"14","author":"P Montuschi","year":"2007","unstructured":"Montuschi P, Barnes P, Roberts LJ II (2007) Insights into oxidative stress: the isoprostanes. Curr Med Chem 14:703\u2013717","journal-title":"Curr Med Chem"},{"key":"2805_CR117","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/antiox6020042","volume":"6","author":"C Chen","year":"2017","unstructured":"Chen C, Li L, Zhou HJ, Min W (2017) The role of NOX4 and TRX2 in angiogenesis and their potential cross-talk. Antioxidants 6:42","journal-title":"Antioxidants"},{"key":"2805_CR118","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.expneurol.2016.11.008","volume":"288","author":"C Geis","year":"2017","unstructured":"Geis C, Geuss E, Sommer C, Schmidt HH, Kleinschnitz C (2017) NOX4 is an early initiator of neuropathic pain. Exp Neurol 288:94\u2013103","journal-title":"Exp Neurol"},{"key":"2805_CR119","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ejpain.2005.08.006","volume":"10","author":"AK Naik","year":"2006","unstructured":"Naik AK, Tandan SK, Dudhgaonkar SP, Jadhav SH, Kataria M, Prakash VR, Kumar D (2006) Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-l-cysteine in rats. Eur J Pain 10:573\u2013579","journal-title":"Eur J Pain"},{"key":"2805_CR120","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1152\/ajpregu.00338.2003","volume":"286","author":"JM Orshal","year":"2004","unstructured":"Orshal JM, Khalil RA (2004) Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286:233\u2013249","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2805_CR121","first-page":"477","volume-title":"Chapter 21: adaptation of skeletal structure to mechanical loading. Osteoporosis","author":"MCH Meulen Van der","year":"2013","unstructured":"Van der Meulen MCH, Hernandez MCJ (2013) Chapter 21: adaptation of skeletal structure to mechanical loading. Osteoporosis, 4th edn. Elsevier, Amsterdam, pp 477\u2013495","edition":"4"},{"key":"2805_CR122","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s10067-013-2212-8","volume":"32","author":"M Mart\u00ednez-Jauand","year":"2013","unstructured":"Mart\u00ednez-Jauand M, Sitges C, Femenia J, Cifre I, Gonz\u00e1lez S, Chialvo D, Montoya P (2013) Age-of-onset of menopause is associated with enhanced painful and non-painful sensitivity in fibromyalgia. Clin Rheumatol 32:975\u2013981","journal-title":"Clin Rheumatol"},{"key":"2805_CR123","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jpain.2017.11.013","volume":"19","author":"M Schertzinger","year":"2018","unstructured":"Schertzinger M, Wesson-Sides K, Parkitny L, Younger J (2018) Daily fluctuations of progesterone and testosterone are associated with fibromyalgia pain severity. J Pain 19:410\u2013417","journal-title":"J Pain"},{"key":"2805_CR124","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.intimp.2015.05.016","volume":"27","author":"HD White","year":"2015","unstructured":"White HD, Brown LA, Gyurik RJ, Manganiello PD, Robinson TD, Hallock LS, Lewis LD, Yeo KT (2015) Treatment of pain in fibromyalgia patients with testosterone gel: pharmacokinetics and clinical response. Int Immunopharmacol 27:249\u2013256","journal-title":"Int Immunopharmacol"},{"key":"2805_CR125","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/204946370800200206","volume":"2","author":"K Vincent","year":"2008","unstructured":"Vincent K, Tracey I (2008) Hormones and their interaction with the pain experience. Rev Pain 2:20\u201324","journal-title":"Rev Pain"},{"key":"2805_CR126","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.psyneuen.2011.07.007","volume":"37","author":"CN Epperson","year":"2012","unstructured":"Epperson CN, Amin Z, Ruparel K, Gur R, Loughead J (2012) Interactive effects of estrogen and serotonin on brain activation during working memory and affective processing in menopausal women. Psychoneuroendocrinology 37:372\u2013382","journal-title":"Psychoneuroendocrinology"},{"key":"2805_CR127","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/art.38905","volume":"67","author":"GT Jones","year":"2015","unstructured":"Jones GT, Atzeni F, Beasley M, Fl\u00fc\u00df E, Sarzi-Puttini P, Macfarlane GJ (2015) The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol 67:568\u2013575","journal-title":"Arthritis Rheumatol"},{"key":"2805_CR128","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0162-3109(95)00033-6","volume":"31","author":"DJ Carr","year":"1995","unstructured":"Carr DJ, Serou M (1995) Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology 31:59\u201371","journal-title":"Immunopharmacology"},{"key":"2805_CR129","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.brs.2017.06.006","volume":"10","author":"EM Khedr","year":"2017","unstructured":"Khedr EM, Omran EAH, Ismail NM, El-Hammady DH, Goma SH, Kotb H, Galal H, Osman AM, Farghaly HSM, Karim AA, Ahmed GA (2017) Effects of transcranial direct current stimulation on pain, mood and serum endorphin level in the treatment of fibromyalgia: a double blinded, randomized clinical trial. Brain Stimul 10:893\u2013901","journal-title":"Brain Stimul"},{"key":"2805_CR130","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1227\/00006123-198005000-00016","volume":"6","author":"RJ Ignelzi","year":"1980","unstructured":"Ignelzi RJ, Atkinson JH (1980) Pain and its modulation. Part 2. Efferent mechanisms. Neurosurgery 6:584\u2013590","journal-title":"Neurosurgery"},{"key":"2805_CR131","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0304-3959(02)00464-5","volume":"104","author":"YG Sun","year":"2003","unstructured":"Sun YG, Lundeberg T, Yu LC (2003) Involvement of endogenous beta-endorphin in antinociception in the arcuate nucleus of hypothalamus in rats with inflammation. Pain 104:55\u201363","journal-title":"Pain"},{"key":"2805_CR132","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/S0022-5347(05)65664-9","volume":"166","author":"AR Shahed","year":"2001","unstructured":"Shahed AR, Shoskes DA (2001) Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol 166:1738\u20131741","journal-title":"J Urol"},{"key":"2805_CR133","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2474-5-48","volume":"5","author":"JN Baraniuk","year":"2004","unstructured":"Baraniuk JN, Whalen G, Cunningham J, Clauw DJ (2004) Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 5:48","journal-title":"BMC Musculoskelet Disord"},{"key":"2805_CR134","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.1016\/S0022-510X(97)86542-2","volume":"150","author":"MD Fiquerola","year":"1997","unstructured":"Fiquerola MD, Loe WH, Barontini M (1997) Plasma met-enkephalin response to local treatment in patients with fibromyalgia. J Neurol Sci 150:S335","journal-title":"J Neurol Sci"},{"key":"2805_CR135","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0304-3959(91)90068-9","volume":"46","author":"H Vaer\u00f8y","year":"1991","unstructured":"Vaer\u00f8y H, Nyberg F, Terenius L (1991) No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7. Pain 46:139\u2013143","journal-title":"Pain"},{"key":"2805_CR136","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1526-4637.2009.00613.x","volume":"10","author":"J Younger","year":"2009","unstructured":"Younger J, Mackey S (2009) Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med 10:663\u2013672","journal-title":"Pain Med"},{"key":"2805_CR137","first-page":"1804","volume":"15","author":"H Vaeroy","year":"1988","unstructured":"Vaeroy H, Helle R, F\u00f8rre O, K\u00e5ss E, Terenius L (1988) Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 15:1804\u20131806","journal-title":"J Rheumatol"},{"key":"2805_CR138","first-page":"183","volume":"13","author":"MB Yunus","year":"1986","unstructured":"Yunus MB, Denko CW, Masi AT (1986) Serum beta-endorphin in primary fibromyalgia syndrome: a controlled study. J Rheumatol 13:183\u2013186","journal-title":"J Rheumatol"},{"key":"2805_CR139","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3959(02)00053-2","volume":"99","author":"DD Price","year":"2002","unstructured":"Price DD, Staud R, Robinson ME, Mauderli AP, Cannon R, Vierck CJ (2002) Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 99:49\u201359","journal-title":"Pain"},{"key":"2805_CR140","doi-asserted-by":"publisher","first-page":"e5180","DOI":"10.1371\/journal.pone.0005180","volume":"4","author":"JW Younger","year":"2009","unstructured":"Younger JW, Zautra AJ, Cummins ET (2009) Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology. PLoS ONE 4:e5180","journal-title":"PLoS ONE"},{"key":"2805_CR141","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s00296-003-0290-7","volume":"23","author":"E Kozanoglu","year":"2003","unstructured":"Kozanoglu E, Canataroglu A, Abayli B, Colakoglu S, Goncu K (2003) Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatol Int 23:248\u2013251","journal-title":"Rheumatol Int"},{"key":"2805_CR142","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/rheumatology\/36.9.981","volume":"36","author":"J Rivera","year":"1997","unstructured":"Rivera J, De Diego A, Trinchet M, Garcia Monforte A (1997) Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol 36:981\u2013985","journal-title":"Br J Rheumatol"},{"key":"2805_CR143","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0049-0172(98)80043-7","volume":"28","author":"D Buskila","year":"1998","unstructured":"Buskila D, Shnaider A, Neumann L, Lorber M, Zilberman D, Hilzenrat N, Kuperman OJ, Sikuler E (1998) Musculoskeletal manifestations and autoantibody profilein 90 hepatitis C virus infected israeli patients. Semin Athritis Rheum 28:107\u2013113","journal-title":"Semin Athritis Rheum"},{"key":"2805_CR144","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","volume":"42","author":"P Cacoub","year":"1999","unstructured":"Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Charles Piette J, Opolon P (1999) Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 42:2204\u20132212","journal-title":"Arthritis Rheum"},{"key":"2805_CR145","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.149.10.3339","volume":"149","author":"MJ Koziel","year":"1992","unstructured":"Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD (1992) Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149:3339\u20133344","journal-title":"J Immunol"},{"key":"2805_CR146","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/hep.510240102","volume":"24","author":"TV Cacciarelli","year":"1996","unstructured":"Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM (1996) Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and post treatment with interferon alfa. Hepatology 24:6\u20139","journal-title":"Hepatology"},{"key":"2805_CR147","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/BF02229708","volume":"15","author":"A Sivri","year":"1996","unstructured":"Sivri A, Cinda\u015f A, Dincer F, Sivri B (1996) Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. Clin Rheumatol 15:283\u2013286","journal-title":"Clin Rheumatol"},{"key":"2805_CR148","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s003840100299","volume":"16","author":"E Lubrano","year":"2001","unstructured":"Lubrano E, Iovino P, Tremolaterra F, Parsons WJ, Ciacci C, Mazzacca G (2001) Fibromyalgia in patients with irritable bowel syndrome. Int J Colorectal Dis 16:211\u2013215","journal-title":"Int J Colorectal Dis"},{"key":"2805_CR149","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/11024159850191210","volume":"583","author":"L Chang","year":"1998","unstructured":"Chang L (1998) The association of functional gastrointestinal disorders and fibromyalgia. Eur J Sur Suppl 583:32\u201336","journal-title":"Eur J Sur Suppl"},{"key":"2805_CR150","doi-asserted-by":"publisher","first-page":"e6657","DOI":"10.1097\/MD.0000000000006657","volume":"96","author":"TY Yang","year":"2017","unstructured":"Yang TY, Chen CS, Lin CL, Lin WM, Kuo CN, Kao CH (2017) Risk for irritable bowel syndrome in fibromyalgia patients: a national database study. Medicine 96:e6657","journal-title":"Medicine"},{"key":"2805_CR151","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/gutjnl-2011-300265","volume":"61","author":"YB Yu","year":"2012","unstructured":"Yu YB, Zuo XL, Zhao QJ, Chen FX, Yang J, Dong YY, Wang P, Li YQ (2012) Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome. Gut 61:685\u2013694","journal-title":"Gut"},{"key":"2805_CR152","doi-asserted-by":"publisher","first-page":"20320","DOI":"10.1038\/srep20320","volume":"6","author":"P Wang","year":"2016","unstructured":"Wang P, Du C, Chen FX, Li CQ, Yu YB, Han T, Akhtar S, Zuo XL, Tan XD, Li YQ (2016) BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit. Sci Rep 6:20320","journal-title":"Sci Rep"},{"key":"2805_CR153","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12883-017-0863-9","volume":"17","author":"BG Malatji","year":"2017","unstructured":"Malatji BG, Meyer H, Mason S, Engelke UF, Wevers RA, Van Reenen M, Reinecke CJ (2017) A diagnostic biomarker profile for fibromyalgia syndrome based on an NMR metabolomics study of selected patients and controls. BMC Neurol 17:88","journal-title":"BMC Neurol"},{"key":"2805_CR154","doi-asserted-by":"publisher","first-page":"10965","DOI":"10.1038\/s41598-018-29388-5","volume":"8","author":"P Roman","year":"2018","unstructured":"Roman P, Est\u00e9vez AF, Miras A, S\u00e1nchez-Labraca N, Ca\u00f1adas F, Vivas AB, Cardona D (2018) A pilot randomized controlled trial to explore cognitive and emotional effects of probiotics in fibromyalgia. Sci Rep 8:10965","journal-title":"Sci Rep"},{"key":"2805_CR155","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1053\/gast.2000.18152","volume":"119","author":"JB Meddings","year":"2000","unstructured":"Meddings JB, Swain MG (2000) Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology 119:1019","journal-title":"Gastroenterology"},{"key":"2805_CR156","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fpsyt.2018.00223","volume":"9","author":"L Liu","year":"2018","unstructured":"Liu L, Zhu G (2018) Gut-brain axis and mood disorder. Front Psychiatry 9:223","journal-title":"Front Psychiatry"},{"key":"2805_CR157","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4161\/gmic.19625","volume":"3","author":"PD Cani","year":"2012","unstructured":"Cani PD, Osto M, Geurts L, Everard A (2012) Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3:279\u2013288","journal-title":"Gut Microbes"},{"key":"2805_CR158","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S1566-0702(00)00220-4","volume":"85","author":"R Dantzer","year":"2000","unstructured":"Dantzer R, Konsman JP, Bluth\u00e9 RM, Kelley KW (2000) Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci 85:60\u201365","journal-title":"Auton Neurosci"},{"key":"2805_CR159","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jpsychires.2016.07.019","volume":"82","author":"JR Kelly","year":"2016","unstructured":"Kelly JR, Borre Y, O\u2019Brien C, Patterson E, El Aidy S, Deane J, Kennedy PJ, Beers S, Scott K, Moloney G, Hoban AE (2016) Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatry Res 82:109\u2013118","journal-title":"J Psychiatry Res"},{"key":"2805_CR160","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3389\/fpsyt.2018.00730","volume":"9","author":"E Aizawa","year":"2018","unstructured":"Aizawa E, Tsuji H, Asahara T, Takahashi T, Teraishi T, Yoshida S, Koga N, Hattori K, Ota M, Kunugi H (2018) Bifidobacterium and Lactobacillus counts in the gut microbiota of patients with bipolar disorder and healthy controls. Front Psychiatry 9:730","journal-title":"Front Psychiatry"},{"key":"2805_CR161","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1037\/h0084280","volume":"45","author":"AM Anch","year":"1991","unstructured":"Anch AM, Lue FA, MacLean AW, Moldofsky H (1991) Sleep physiology and psychological aspects of the fibrositis (fibromyalgia) syndrome. Can J Psychol 45:179\u2013184","journal-title":"Can J Psychol"},{"key":"2805_CR162","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2474-8-27","volume":"8","author":"RM Bennett","year":"2007","unstructured":"Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L (2007) An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 8:27","journal-title":"BMC Musculoskelet Disord"},{"key":"2805_CR163","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00482-007-0602-z","volume":"22","author":"W H\u00e4user","year":"2008","unstructured":"H\u00e4user W, Zimmer C, Felde E, K\u00f6llner V (2008) What are the key symptoms of fibromyalgia? Results of a survey of the German fibromyalgia association. Schmerz 22:176\u2013183","journal-title":"Schmerz"},{"key":"2805_CR164","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0304-3959(96)03226-5","volume":"68","author":"G Affleck","year":"1996","unstructured":"Affleck G, Urrows S, Tennen H, Higgins P, Abeles M (1996) Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 68:363\u2013368","journal-title":"Pain"},{"key":"2805_CR165","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0010-440X(99)90008-1","volume":"40","author":"MY A\u011farg\u00fcn","year":"1999","unstructured":"A\u011farg\u00fcn MY, Tekeo\u011flu I, G\u00fcne\u015f A, Adak B, Kara H, Ercan M (1999) Sleep quality and pain threshold in patients with fibromyalgia. Compr Psychiatry 40:226\u2013228","journal-title":"Compr Psychiatry"},{"key":"2805_CR166","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/rheumatology\/kel363","volume":"46","author":"A Gupta","year":"2007","unstructured":"Gupta A, Silman AJ, Ray D, Morriss R, Dickens C, MacFarlane GJ, Chiu YH, Nicholl B, McBeth J (2007) The role of psychosocial factors in predicting the onset of chronic widespread pain: results from a prospective population-based study. Rheumatology 46:666\u2013671","journal-title":"Rheumatology"},{"key":"2805_CR167","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/art.23828","volume":"59","author":"SM Bigatti","year":"2008","unstructured":"Bigatti SM, Hernandez AM, Cronan TA, Rand KL (2008) Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum 59:961\u2013967","journal-title":"Arthritis Rheum"},{"key":"2805_CR168","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.comppsych.2012.03.008","volume":"53","author":"G Consoli","year":"2012","unstructured":"Consoli G, Marazziti D, Ciapparelli A, Bazzichi L, Massimetti G, Giacomelli C, Rossi A, Bombardieri S, Dell\u2019Osso L (2012) The impact of mood, anxiety, and sleep disorders on fibromyalgia. Compr Psychiatry 53:962\u2013967","journal-title":"Compr Psychiatry"},{"key":"2805_CR169","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15537\/smj.2017.5.17864","volume":"38","author":"B Keskindag","year":"2017","unstructured":"Keskindag B, Karaaziz M (2017) The association between pain and sleep in fibromyalgia. Saudi Med J 38:5","journal-title":"Saudi Med J"},{"key":"2805_CR170","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0893-133X(02)00369-X","volume":"27","author":"K Lieb","year":"2002","unstructured":"Lieb K, Ahlvers K, Dancker K, Strohbusch S, Reincke M, Feige B, Berger M, Riemann D, Voderholzer U (2002) Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men. Neuropsychopharmacology 27:1041\u20131049","journal-title":"Neuropsychopharmacology"},{"key":"2805_CR171","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.bbr.2005.09.008","volume":"167","author":"ML Andersen","year":"2006","unstructured":"Andersen ML, Nascimento DC, Machado RB, Roizenblatt S, Moldofsky H, Tufik S (2006) Sleep disturbance induced by substance P in mice. Behav Brain Res 167:212\u2013218","journal-title":"Behav Brain Res"},{"key":"2805_CR172","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jcmgh.2015.03.003","volume":"1","author":"A Sideri","year":"2015","unstructured":"Sideri A, Bakirtzi K, Shih DQ, Koon HW, Fleshner P, Arsenescu R, Arsenescu V, Turner JR, Karagiannides I, Pothoulakis C (2015) Substance-P mediates pro-inflammatory cytokine release form mesenteric adipocytes in inflammatory bowel disease patients. Cell Mol Gastroenterol Hepatol 1:420\u2013432","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2805_CR173","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11926-002-0039-4","volume":"4","author":"RM Bennett","year":"2002","unstructured":"Bennett RM (2002) Adult growth hormone deficiency in patients with fibromyalgia. Curr Rheumatol Rep 4:306\u2013312","journal-title":"Curr Rheumatol Rep"},{"key":"2805_CR174","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1210\/jc.2010-0061","volume":"95","author":"G Cuatrecasas","year":"2010","unstructured":"Cuatrecasas G, Gonzalez MJ, Alegre C, Sesmilo G, Fernandez-Sol\u00e0 J, Casanueva FF, Garcia-Fructuoso F, Poca-Dias V, Izquierdo JP, Puig-Domingo M (2010) High prevalence of growth hormone deficiency in severe fibromyalgia syndromes. J Clin Endocrinol Metab 95:4331\u20134337","journal-title":"J Clin Endocrinol Metab"},{"key":"2805_CR175","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/art.10209","volume":"46","author":"ES Paiva","year":"2002","unstructured":"Paiva ES, Deodhar A, Jones KD, Bennett R (2002) Impaired growth hormone secretion in fibromyalgia patients: evidence for augmented hypothalamic somatostatin tone. Arthritis Rheum 46:1344\u20131350","journal-title":"Arthritis Rheum"},{"key":"2805_CR176","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/ajpregu.1999.277.5.R1297","volume":"277","author":"L Beranek","year":"1999","unstructured":"Beranek L, Hajdu I, Gardi J, Taishi P, Ob\u00e1l F Jr, Krueger JM (1999) Central administration of the somatostatin analog octreotide induces captopril-insensitive sleep responses. Am J Physiol Regul Integr Comp Physiol 277:1297\u20131304","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2805_CR177","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/sj.npp.1300298","volume":"29","author":"M Ziegenbein","year":"2004","unstructured":"Ziegenbein M, Held K, Kuenzel HE, Murck H, Antonijevic IA, Steiger A (2004) The somatostatin analogue octreotide impairs sleep and decreases EEG sigma power in young male subjects. Neuropsychopharmacology 29:146","journal-title":"Neuropsychopharmacology"},{"key":"2805_CR178","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2474-8-27","volume":"8","author":"RM Bennett","year":"2007","unstructured":"Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L (2007) An internet survey of 2,596 people with fibromyalgia. BMC Musculoskel Disord 8:27","journal-title":"BMC Musculoskel Disord"},{"key":"2805_CR179","first-page":"469","volume":"17","author":"R Bou Khalil","year":"2016","unstructured":"Bou Khalil R, Khoury E, Richa S (2016) Do fibromyalgia flares have a neurobiological substrate? Pain Med 17:469\u2013475","journal-title":"Pain Med"},{"key":"2805_CR180","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.7717\/peerj.2421","volume":"4","author":"JN Ablin","year":"2016","unstructured":"Ablin JN, Zohar AH, Zaraya-Blum R, Buskila D (2016) Distinctive personality profiles of fibromyalgia and chronic fatigue syndrome patients. Peer J 4:2421","journal-title":"Peer J"},{"key":"2805_CR181","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1523\/JNEUROSCI.2584-06.2007","volume":"27","author":"LK Heisler","year":"2007","unstructured":"Heisler LK, Pronchuk N, Nonogaki K, Zhou L, Raber J, Tung L, Yeo GS, O\u2019Rahilly S, Colmers WF, Elmquist JK, Tecott LH (2007) Serotonin activates the hypothalamic\u2013pituitary\u2013adrenal axis via serotonin 2C receptor stimulation. J Neurosci 27:6956\u20136964","journal-title":"J Neurosci"},{"key":"2805_CR182","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0165-5728(95)00066-B","volume":"60","author":"MR Opp","year":"1995","unstructured":"Opp MR, Smith EM, Hughes TK Jr (1995) Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. J Neuroimmunol 60:165\u2013168","journal-title":"J Neuroimmunol"},{"key":"2805_CR183","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1089\/107999099313244","volume":"19","author":"T Kushikata","year":"1999","unstructured":"Kushikata T, Fang J, Krueger JM (1999) Interleukin-10 inhibits spontaneous sleep in rabbits. J Interferon Cytokine Res 19:1025\u20131030","journal-title":"J Interferon Cytokine Res"},{"key":"2805_CR184","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0306-4522(89)90234-0","volume":"28","author":"M Denoyer","year":"1989","unstructured":"Denoyer M, Sallanon M, Kitahama K, Aubert C, Jouvet M (1989) Reversibility of para-chlorophenylalanine-induced insomnia by intrahypothalamic microinjection of L-5-hydroxytryptophan. Neuroscience 28:83\u201394","journal-title":"Neuroscience"},{"key":"2805_CR185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0166-4328(81)90035-8","volume":"2","author":"AA Borb\u00e9ly","year":"1981","unstructured":"Borb\u00e9ly AA, Neuhaus HU, Tobler I (1981) Effect of p-chlorophenylalanine and tryptophan on sleep, EEG and motor activity in the rat. Behav Brain Res 2:1\u201322","journal-title":"Behav Brain Res"},{"key":"2805_CR186","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1152\/ajpregu.2001.280.6.R1806","volume":"280","author":"LA Toth","year":"2001","unstructured":"Toth LA, Opp MR (2001) Cytokine- and microbially induced sleep responses of interleukin-10 deficient mice. Am J Physiol Regul Integr Comp Physiol 280:1806\u20131814","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2805_CR187","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0166-4328(94)90105-8","volume":"65","author":"OE Olsen","year":"1994","unstructured":"Olsen OE, Neckelmann D, Ursin R (1994) Diurnal differences in l-tryptophan sleep and temperature effects in the rat. Behav Brain Res 65:195\u2013203","journal-title":"Behav Brain Res"},{"key":"2805_CR188","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1526-4610.2006.00337.x","volume":"46","author":"P Sarchielli","year":"2006","unstructured":"Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46:200\u2013207","journal-title":"Headache"},{"key":"2805_CR189","first-page":"173","volume":"43","author":"LA Bradley","year":"2000","unstructured":"Bradley LA, Weigent DA, Sotolongo A, Alorcon GS, Arnold RE, Cianfrini LR (2000) Blood serum levels of nitric oxide are elevated in women with fibromyalgia:possible contributions to central and peripheral sensitization. Arthritis Rheum 43:173","journal-title":"Arthritis Rheum"},{"key":"2805_CR190","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/0028-3908(93)90020-4","volume":"32","author":"M Lafon-Cazal","year":"1993","unstructured":"Lafon-Cazal M, Culcasi M, Gaven F, Pietri S, Bockaert J (1993) Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology 32:1259\u20131266","journal-title":"Neuropharmacology"},{"key":"2805_CR191","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0959-4388(97)80065-7","volume":"7","author":"JE Brenman","year":"1997","unstructured":"Brenman JE, Bredt DS (1997) Synaptic signaling by nitric oxide. Curr Opin Neurobiol 7:374\u2013378","journal-title":"Curr Opin Neurobiol"},{"key":"2805_CR192","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s004410051224","volume":"295","author":"P Callsen-Cencic","year":"1999","unstructured":"Callsen-Cencic P, Hoheisel U, Kaske A, Mense S, Tenschert S (1999) The controversy about spinal neuronal nitric oxide synthase: under which conditions is it up- or downregulated? Cell Tissue Res 295:183\u2013194","journal-title":"Cell Tissue Res"},{"key":"2805_CR193","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0006-8993(94)91246-7","volume":"637","author":"P Li","year":"1994","unstructured":"Li P, Tong C, Eisenach JC, Figueroa JP (1994) NMDA causes release of nitric oxide from rat spinal cord in vitro. Brain Res 637:287\u2013291","journal-title":"Brain Res"},{"key":"2805_CR194","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.1039\/C3CS60467E","volume":"43","author":"P Mukherjee","year":"2011","unstructured":"Mukherjee P, Cinelli MA, Kang S, Silverman RB (2011) Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain. Chem Soc Rev 43:6814\u20136838","journal-title":"Chem Soc Rev"},{"key":"2805_CR195","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/WNL.0b013e318233b3e4","volume":"77","author":"EE Benarroch","year":"2011","unstructured":"Benarroch EE (2011) Nitric oxide a pleiotropic signal in the nervous system. Neurology 77:1568\u20131576","journal-title":"Neurology"},{"key":"2805_CR196","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0361-9230(94)00229-T","volume":"36","author":"NT Sandor","year":"1995","unstructured":"Sandor NT, Brassai A, Pliskas A, Lendvai B (1995) Role of nitric oxide in modulating neurotransmitter release from rat striatum. Brain Res Bull 36:483\u2013486","journal-title":"Brain Res Bull"},{"key":"2805_CR197","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.tips.2004.09.007","volume":"25","author":"TC Theoharides","year":"2004","unstructured":"Theoharides TC, Donelan JM, Papadopoulou N, Cao J, Kempuraj D, Conti P (2004) Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 25:563\u2013568","journal-title":"Trends Pharmacol Sci"},{"key":"2805_CR198","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.4049\/jimmunol.174.12.7665","volume":"174","author":"J Cao","year":"2005","unstructured":"Cao J, Papadopoulou N, Kempuraj D, Boucher WS, Sugimoto K, Cetrulo CL, Theoharides TC (2005) Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 174:7665\u20137675","journal-title":"J Immunol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-019-02805-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-019-02805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T22:13:30Z","timestamp":1694816010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-019-02805-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":198,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2805"],"URL":"https:\/\/doi.org\/10.1007\/s11064-019-02805-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]},"assertion":[{"value":"20 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}